海外の治験の状況「COVID-19」での検索結果
7件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Not recruiting
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 y
- Hepatitis B
- Austria
- 2008-06-13
Not Recruiting
- Impact of rhCu/Zn SOD on inflammation-induced impairment of vascular reactivity - LPS-rhSOD
- 43 healthy male subjects, age 19-45 yrs. Nonsmokers
- Austria
- 2005-05-23
Not recruiting
- Feasibility of an Individual Placement and Support (IPS) prototype for young people aged 18-19 with mild and moderate mental health conditions developed by the Community Mental Health Service at Odyssey House in Christchurch, "Taking Charge",
- mental health
- New Zealand
- 2018-03-09
Not recruiting
- Youth e-therapy – Evaluation of a computerised cognitive behavioural therapy (CCBT) self-help programme for adolescents with mild to moderate depression
- Adolescents aged 12-19 with mild to moderate depressive symptoms
- New Zealand
- 2009-05-12
Recruiting
- Copeptin Registry (proCORE) Biomarkers in Cardiology (BIC)-19
- ;I21 - Acute myocardial infarction
- Austria, France, Germany, Hungary, Lithuania, Switzerland, Turkey, United Kingdom
- 2015-06-24
Not recruiting
- Youth e-therapy - Evaluation of a computerised self-help programme for same/both-sex attracted adolescents and young people questioning their sexuality with mild to moderate depression
- Same/both-sex attracted adolescents and young people questioning their sexuality aged 16 to 19 years old with mild to moderate depressive symptoms
- ,Outside, New Zealand
- 2009-09-18
Not Recruiting
- A Randomized Two-by-Two, Multicenter, Open-Label Phase III Study of BMS-354825 Administered Orally at a Dose of 50 mg or 70 mg Twice Daily or 100 mg or 140 mg Once Daily in Subjects with Chronic Phase Philadelphia Chromosome or BCR-ABL Positive Chronic Myelogenous Leukemia Who are Resistant or Intolerant to Imatinib Mesylate. Revised Protocol 05, incorporating Administrative Letters 01, 02, 03 and 04 and Amendments 01, 02, 03 (v1.0, dated 28-Feb-2008) and 04 (v1.0, dated 19-Dec-2008)
- Subjects with Chronic Phase Philadelphia Chromosome or BCR-ABL Positive Chronic Myelogenous Leukemia who are resistant or intolerant to Imatinib Mesylate
- Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, Germany, Hungary, Ireland, Italy, Spain, Sweden, United Kingdom
- 2005-06-13
- 1